Posted by Michael Wonder on 10 Nov 2025
ICER releases draft scope on vaccines for Covid-19
10 November 2025 - Report will be subject of New England CEPAC meeting in June 2026; draft scoping document open to public comment until 2 December 2025.
The ICER has posted a draft scoping document outlining how we plan to conduct an assessment of the comparative clinical effectiveness and value of Comirnaty (Pfizer, BioNTech), Spikevax (Moderna), mNexspike (Moderna), and Nuvaxovid (Sanofi) for the protection against Covid-19, including both the short- and long-term effects of the infection.
